Try
ALNYLAM PHARMACEUTICALS, INC.
ALNYUnited States
72 filed reports · 493 financial concepts · 2 earnings calls · 0 media appearances
Filed reports
72 reports · Jun 2014 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 119 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 37 | 4,618 | Jun 2014 to Jun 2026 |
| Current · 8-KSEC EDGAR | 23 | 94 | Mar 2020 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 12 | 4,920 | Dec 2014 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Jul 30, 2026 | 369 | Open |
| FY2026 Q2 | 8-K | Jun 30, 2026 | Jul 30, 2026 | 8 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | Apr 30, 2026 | 225 | Open |
| FY2026 Q1 | 8-K | Mar 31, 2026 | Apr 30, 2026 | 7 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 12, 2026 | 896 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Jan 12, 2026 | 5 | Open |
| FY2025 Q3 | 8-K | Sep 30, 2025 | Oct 30, 2025 | 4 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Oct 30, 2025 | 267 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Jul 31, 2025 | 141 | Open |
| FY2025 Q2 | 8-K | Jun 30, 2025 | Jul 31, 2025 | 4 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 1, 2025 | 147 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Feb 13, 2025 | 406 | Open |
Financial data
493 concepts · 9,632 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial474 concepts · 8,810 facts · Feb 2012 to Jul 2026
- Cash and cash equivalents at carrying value68 · Dec 2012 to Jun 2026
- Net income loss68 · Dec 2012 to Jun 2026
- Comprehensive income net of tax67 · Dec 2012 to Jun 2026
- Nonoperating income expense67 · Dec 2012 to Jun 2026
- Operating income loss67 · Dec 2012 to Jun 2026
- Other comprehensive income unrealized holding gain loss on securities arising during period net of tax67 · Dec 2012 to Jun 2026
- Research and development expense67 · Dec 2012 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets66 · Dec 2012 to Jun 2026
- Other nonoperating income expense66 · Dec 2012 to Jun 2026
- Payments to acquire available for sale securities debt66 · Dec 2012 to Jun 2026
- Payments to acquire property plant and equipment66 · Dec 2012 to Jun 2026
- Proceeds from issuance of shares under incentive and share based compensation plans including stock options66 · Dec 2012 to Jun 2026
- Share based compensation66 · Dec 2012 to Jun 2026
- Stockholders equity (US GAAP)65 · Dec 2012 to Jun 2026
- Retained earnings accumulated deficit64 · Dec 2013 to Jun 2026
- Accounts payable current63 · Dec 2013 to Jun 2026
- Accrued liabilities current63 · Dec 2013 to Jun 2026
- Accumulated other comprehensive income loss net of tax63 · Dec 2013 to Jun 2026
- Additional paid in capital common stock63 · Dec 2013 to Jun 2026
- Assets63 · Dec 2013 to Jun 2026
- Assets current63 · Dec 2013 to Jun 2026
- Available for sale securities debt securities current63 · Dec 2013 to Jun 2026
- Common stock par or stated value per share63 · Dec 2013 to Jun 2026
- Common stock shares authorized63 · Dec 2013 to Jun 2026
Product3 concepts · 710 facts · Dec 2017 to Jun 2026
- Revenue670 · Dec 2017 to Jun 2026
- Accounts Receivable, Net39 · Dec 2018 to Jun 2026
- Chargebacks and Rebates1 · Dec 2018
Guidance14 concepts · 108 facts · May 2020 to Jul 2026
- Revenue Guidance32 · May 2020 to Jul 2026
- Revenue Growth Guidance19 · Jan 2021 to Jul 2026
- Revenue Guidance (Combined net product revenues for ONPATTRO, GIVLAARI, and OXLUMO)10 · Feb 2021 to May 2023
- Revenue Guidance (Net revenues from collaborations and royalties)10 · Feb 2021 to May 2023
- Operating Margin Guidance8 · Jan 2026 to Jul 2026
- Revenue Growth Guidance (Net Product Revenue; Constant currency)8 · May 2023 to Jul 2026
- Revenue Growth Guidance (Net Product Revenue)6 · May 2023 to Feb 2024
- Revenue Guidance (collaborations and royalties)4 · Aug 2023 to Feb 2024
- Revenue Growth Guidance (net product revenues; At current exchange rates)2 · Jul 2026
- Revenue Guidance (collaborations and royalties; At current exchange rates)2 · Jul 2026
- Revenue Guidance (Net product revenues)2 · Feb 2024
- Revenue Guidance (net product revenues; At current exchange rates)2 · Jul 2026
- Revenue Guidance (ONPATTRO, AMVUTTRA, GIVLAARI and OXLUMO)2 · Aug 2023
- Revenue Growth Guidance (combined net product revenues for our three wholly owned commercial brands)1 · Feb 2021
Segment2 concepts · 4 facts · Jun 2025 to Jun 2026
- Research and development expense2 · Jun 2025 to Jun 2026
- Selling general and administrative expense2 · Jun 2025 to Jun 2026
Segments
714 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or service10 members · 710 facts
- ONPATTRO147 · Dec 2018 to Jun 2026
- GIVLAARI144 · Dec 2018 to Jun 2026
- OXLUMO129 · Dec 2018 to Jun 2026
- Amvuttra102 · Dec 2020 to Jun 2026
- Product68 · Dec 2017 to Jun 2026
- Product39 · Dec 2018 to Jun 2026
- Royalty32 · Dec 2019 to Jun 2026
- Collaborations23 · Dec 2021 to Jun 2026
- Rare13 · Dec 2023 to Jun 2026
- TTR13 · Dec 2023 to Jun 2026
Statement business segments1 member · 4 facts
- Single Reportable4 · Jun 2025 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary90 claims from 7 reports · Dec 2024 to Jun 2026
- Management discussion (MD&A) commentary154 claims from 8 reports · Sep 2024 to Jun 2026
- Risk-factor changes28 claims from 1 reports · Dec 2025
- Risk factors111 risks from 2 annual reports · 2024 to 2025
Earnings calls
2 calls · Apr 2026 to Jul 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Jul 30, 2026
- FY2026 Q1Apr 30, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.